Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Abstract Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40263-022-00955-9. Authors: Adam Strzelczyk ⚬, Susanne Schubert-Bast ⚬ Affiliations: grid.411088.40000 0004 0578 8220Epilepsy Center Frankfurt Rhine-Main, Center of Neurology and Neurosurgery, Goethe-University and University Hospital Frankfurt, Schleusenweg 2-16, 60528 Frankfurt am Main, Germany; grid.7839.50000 0004 1936 9721LOEWE Center for Personalized and Translational Epilepsy Research (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany; grid.411088.40000 0004 0578 8220Department of Neuropediatrics, Goethe-University and University Hospital Frankfurt, Frankfurt am Main, Germany License:
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in
